Provided by Tiger Trade Technology Pte. Ltd.

Disc Medicine

82.01
+2.202.76%
Volume:134.59K
Turnover:10.96M
Market Cap:3.15B
PE:-12.50
High:82.24
Open:79.88
Low:79.33
Close:79.81
52wk High:99.50
52wk Low:40.00
Shares:38.39M
Float Shares:32.95M
Volume Ratio:0.60
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.5619
EPS(LYR):-6.0116
ROE:-39.08%
ROA:-23.96%
PB:4.89
PE(LYR):-13.64

Loading ...

Disc Medicine COO Jonathan Yen-wen Yu Reports Sale of 100 Common Shares for $8,250

Reuters
·
Jul 10

Did Disc Medicine’s Expanded Hercules Credit Access Just Shift IRON’s Funding Risk Profile?

Simply Wall St.
·
Jul 01

Disc Medicine COO Jonathan Yu Disposes of 300 Common Shares Worth $21,750

Reuters
·
Jul 01

Disc Medicine - Enters First Amendment to Loan Agreement on June 25, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 01

Disc Medicine - to Draw Down $30 Mln of Tranche 1-B Advance - SEC Filing

THOMSON REUTERS
·
Jul 01

Disc Medicine Amends Hercules Loan Agreement, Draws Down $30 Million Tranche

Reuters
·
Jul 01

Disc Medicine COO Jonathan Yen-wen Yu Disposes of 9,700 Common Shares Worth $704,795

Reuters
·
Jun 25

Disc Medicine Stockholders Approve Governance and Executive Pay

TIPRANKS
·
Jun 25

Disc Medicine Shareholders Approve Advisory Executive Pay Vote

Reuters
·
Jun 25

Disc Medicine CEO John Quisel disposes of common shares worth $2.38 million

Reuters
·
Jun 24

Disc Medicine COO Yu Jonathan Yen-Wen sells 18,612 shares for USD 1.29 million

Reuters
·
Jun 19

Disc Medicine (IRON) Stock Could Be 64% Below Fair Value After EHA Trial Update

Simply Wall St.
·
Jun 17

Press Release: LABRADOR IRON ORE ROYALTY CORPORATION - CASH DIVIDEND FOR THE SECOND QUARTER OF 2026 - $0.30 PER COMMON SHARE

Dow Jones
·
Jun 17

Disc Medicine Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jun 16

Wedbush Sticks to Its Buy Rating for Disc Medicine (IRON)

TIPRANKS
·
Jun 16

Disc Medicine price target raised to $85 from $80 at Morgan Stanley

TIPRANKS
·
Jun 16

Disc Medicine posts corporate deck highlighting bitopertin in EPP pipeline progress

Reuters
·
Jun 16

Disc Medicine says DISC-0974 posts durable anemia responses in Phase 2 RALLY-MF trial in myelofibrosis

Reuters
·
Jun 12

Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting

GlobeNewswire
·
Jun 12

H.C. Wainwright Remains a Buy on Disc Medicine (IRON)

TIPRANKS
·
Jun 11